Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission
Intestinal permeability is increased in IBD using validated in vivo assay relative to NHV; increased IP in IBD persists during remission.
Authors
- Michael Camilleri (ORCID: https://orcid.org/0000-0001-6472-7514)
- Michael Ryks
- Laura E. Raffals (ORCID: https://orcid.org/0000-0002-5267-2592)
- Katie A. Dunleavy (ORCID: https://orcid.org/0000-0001-9415-4577)
- Irene Busciglio
- Victor Chedid (ORCID: https://orcid.org/0000-0001-8548-9228)
- Chad R Rypstra
- Deborah J. Eckert
- Ellie Omerdic
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1093/ibd/izaf043
- Citations
- 4
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 7.27
Funders
- National Institutes of Health
- Center for Clinical and Translational Science, Mayo Clinic